88 FR 171 pgs. 60987-60988 - Bulk Manufacturer of Controlled Substances Application: SpecGx LLC; Correction
Type: NOTICEVolume: 88Number: 171Pages: 60987 - 60988
Pages: 60987, 60988Docket number: [Docket No. DEA-1176]
FR document: [FR Doc. 2023-19179 Filed 9-5-23; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1176]
Bulk Manufacturer of Controlled Substances Application: SpecGx LLC; Correction
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice; correction.
SUMMARY:
The Drug Enforcement Administration (DEA) published a document in the Federal Register of April 4, 2023, concerning a notice of application for bulk manufacturer of Controlled Substances. That document listed a drug code/controlled substance in error as it was not requested by the registrant (2270-Pentobarbital). Additionally, the document listed duplicates of 7 other drug codes in error (1100, 1105, 1205, 1724, 8333, 9780, 9801).
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of April 4, 2023, in FR Doc. 2023-06952 (88 FR 19990), on page 19990, in columns 1 and 2, under the requested controlled substances/drug codes, it should read as such:
[top]
Controlled substance | Drug code | Schedule |
---|---|---|
Gamma Hydroxybutyric Acid | 2010 | I |
Tetrahydrocannabinols | 7370 | I |
Psilocybin | 7437 | I |
Codeine-N-oxide | 9053 | I |
Noroxymorphone | 9145 | I |
Difenoxin | 9168 | I |
Morphine-N-oxide | 9307 | I |
Normorphine | 9313 | I |
Alphamethadol | 9605 | I |
Betamethadol | 9609 | I |
Norlevorphanol | 9634 | I |
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | 9821 | I |
Butyryl Fentanyl | 9822 | I |
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) | 9850 | I |
Amphetamine | 1100 | II |
Methamphetamine | 1105 | II |
Lisdexamfetamine | 1205 | II |
Methylphenidate | 1724 | II |
Nabilone | 7379 | II |
ANPP (4-Anilino-N-phenethyl-4-piperidine) | 8333 | II |
Phenylacetone | 8501 | II |
Codeine | 9050 | II |
Dihydrocodeine | 9120 | II |
Oxycodone | 9143 | II |
Hydromorphone | 9150 | II |
Diphenoxylate | 9170 | II |
Ecgonine | 9180 | II |
Hydrocodone | 9193 | II |
Levorphanol | 9220 | II |
Isomethadone | 9226 | II |
Meperidine | 9230 | II |
Meperidine intermediate-A | 9232 | II |
Meperidine intermediate-B | 9233 | II |
Meperidine intermediate-C | 9234 | II |
Methadone | 9250 | II |
Methadone intermediate | 9254 | II |
Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II |
Morphine | 9300 | II |
Oripavine | 9330 | II |
Thebaine | 9333 | II |
Opium tincture | 9630 | II |
Opium, powdered | 9639 | II |
Oxymorphone | 9652 | II |
Noroxymorphone | 9668 | II |
Alfentanil | 9737 | II |
Remifentanil | 9739 | II |
Sufentanil | 9740 | II |
Tapentadol | 9780 | II |
Fentanyl | 9801 | II |
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-19179 Filed 9-5-23; 8:45 am]
BILLING CODE P